Literature DB >> 2451505

Renal hypertrophy in experimental diabetes. The activity of the 'de novo' and salvage pathways of purine [corrected] synthesis.

S Kunjara1, S J Beardsley, A L Greenbaum.   

Abstract

Measurements were made of the activity of phosphoribosyl pyrophosphate amidotransferase (PPRibP-At, EC 2.4.2.14) and of adenine (APRT, EC 2.4.2.7) and hypoxanthine (HPRT, EC 2.4.2.8) phosphoribosyltransferases, representing the 'de novo' and salvage pathways respectively. PPRibP-At activity increased within 3 days of diabetes, whereas APRT and HPRT increased later. Incorporation of [14C]formate and of [8-14C]adenine into the nucleic acids of kidney slices showed that formate was incorporated earlier, and to a greater extent, than was adenine. These results indicate that, although the 'de novo' pathway for nucleotide synthesis is the main route in early diabetes, the salvage pathway assumes greater importance at later stages.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451505      PMCID: PMC1148794          DOI: 10.1042/bj2490911

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  A micro-assay method for hypoxanthine-guanine and adenine phosphoribosyltransferases.

Authors:  H Kizaki; T Sakurada
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Properties of 5-phosphoribosyl-1-pyrophosphate amidotransferase from human lymphoblasts.

Authors:  A W Wood; J E Seegmiller
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

4.  Radioassay for enzymic production of glutamate from glutamine.

Authors:  D W Martin
Journal:  Anal Biochem       Date:  1972-03       Impact factor: 3.365

5.  De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  S Brosh; P Boer; B Kupfer; A de Vries; O Sperling
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

6.  Inhibition of phosphoribosylpyrophosphate synthesis by purine nucleosides in human erythrocytes.

Authors:  G Planet; I H Fox
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

7.  Uridine triphosphate and RNA synthesis during diabetes-induced renal growth.

Authors:  P Cortes; N W Levin; F Dumler; A H Rubenstein; C P Verghese; K K Venkatachalam
Journal:  Am J Physiol       Date:  1980-04

8.  Phosphoribosylpyrophosphate bioavailability in diabetic rat renal cortex in vivo.

Authors:  P Cortes; C P Verghese; K K Venkatachalam; A M Schoenberger; N W Levin
Journal:  Am J Physiol       Date:  1980-04

9.  Activities of amidophosphoribosyltransferase (EC2.4.2.14) and the purine phosphoribosyltransferases (EC2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development--their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome.

Authors:  J Allsop; R W Watts
Journal:  J Neurol Sci       Date:  1980-05       Impact factor: 3.181

10.  Renal hypertrophy in streptozotocin-diabetic rats.

Authors:  K Seyer-Hansen
Journal:  Clin Sci Mol Med       Date:  1976-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.